United States

What does the Tax Cuts and Jobs Act mean for life sciences companies?


Join us as RSM’s national life sciences practice presents an overview of the key provisions of the new tax bill, as well as international and state and local considerations for life sciences companies.

In this one-hour session, we’ll discuss key tax considerations for life sciences companies, including:

  • Corporate tax rate reduction
  • Corporate alternative minimum tax (AMT)
  • Ability to carry back net operating losses
  • Limitation of the orphan drug tax credit
  • Research and experimentation (R&E) tax deduction
  • Domestic production activities deduction (DPAD)
  • International tax reform
  • State and local tax considerations

Download webcast slides


Event details

Who should attend
Chief financial officers (CFOs), controllers, tax titles in the life sciences industry


More information
Email Allison Quattlander or call +1 704 442 3838